All of the following are screening tests for cervical cancer, except?

NORCET 2 - 2021 (shift-1)

Obstetrics and Midwifery Nursing

Easy

Appeared in: NORCET 2 - 2021 (shift-1)

Explanation

Colposcopy is a diagnostic procedure, not a primary screening tool for cervical cancer.
It is performed as a follow-up investigation after an abnormal screening result, such as an abnormal Pap smear or a positive HPV DNA test.
The purpose of colposcopy is to use a magnifying instrument (colposcope) to get a detailed view of the cervix, identify the location and extent of abnormal tissue, and guide biopsies for histopathological confirmation.
Screening tests are applied to a broad, asymptomatic population, whereas colposcopy is a targeted examination for individuals with a suspected issue.

Option B: The Pap smear is a cornerstone of cervical cancer screening. It involves collecting cervical cells to examine under a microscope for abnormalities (cytology).
Option C: Visual inspection with acetic acid (VIA) is a widely used, effective, and low-cost screening method, particularly in resource-limited settings. It involves applying dilute acetic acid to the cervix and observing for abnormal areas that turn white.
Option D: Testing for Cervical DNA, specifically for high-risk Human Papillomavirus (HPV) types, is a primary screening method. Since persistent HPV infection is the main cause of cervical cancer, this test identifies women at highest risk.

Visual 1: Flowchart illustrating the cervical cancer management pathway: Screening (Pap/HPV/VIA) -> Positive Result -> Diagnostic Workup (Colposcopy) -> Biopsy -> Treatment.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Cervical Cancer: Screening vs. Diagnostic Tests as background academic context rather than a clinical decision trigger.
A nurse's primary role is patient education. It is crucial to explain the difference between screening and diagnostic tests to alleviate anxiety. A positive screening test does not mean the patient has cancer; it means further investigation (like colposcopy) is needed.
Nurses are responsible for preparing patients for colposcopy, which includes explaining the procedure, ensuring informed consent, providing emotional support, and assisting during the biopsy.
What if a patient has a positive high-risk HPV test but a normal Pap smear? The nurse should explain that this is a common scenario. The patient is at increased risk, but there are no cell changes yet. The likely recommendation is a repeat co-test in 12 months, as the body's immune system often clears the HPV infection on its own.

How to Approach the Question

First, identify the keyword 'except'. This tells you that three of the options are screening tests, and one is not. Your task is to find the outlier.
Define 'screening test' in your mind: a test used to detect potential disease in asymptomatic people from the general population.
Evaluate each option against this definition. Ask yourself, 'Is this a first-line test for all women in a certain age group?'
Pap smear, VIA, and HPV DNA testing are all used for broad population screening.
Colposcopy is only performed after one of the screening tests comes back abnormal. Therefore, it is a diagnostic follow-up, not a screening test.
Select Colposcopy as the option that does not fit the category of a screening test.

Concept Tested & Keywords

QBnIDhFxeOY7gJ59FRLiOT